title: [Lipids: diagnosis and therapy in type 2 diabetes].
abstract: Hyper- and Dyslipidemia contribute to cardiovascular morbidity and mortality in diabetic patients. Pharmacological therapy with statins has convincingly shown to reduce cardiovascular risk in diabetic patients. The present article represents the recommendations of the Austrian Diabetes Association for the use of lipid-lowering drugs in diabetic patients according to current scientific evidence.
authors.affiliation: 1. Medizinische Abteilung, Hanuschkrankenhaus, Wien, Österreich. thomas.wascher@meduni-graz.at
authors.forename: Thomas C
authors.initials: TC
authors.lastname: Wascher
authors.forename: Bernhard
authors.initials: B
authors.lastname: Paulweber
authors.forename: Hermann
authors.initials: H
authors.lastname: Toplak
authors.forename: Christoph
authors.initials: C
authors.lastname: Saely
authors.forename: Heinz
authors.initials: H
authors.lastname: Drexel
mesh_terms: D001317:Austria; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D017410:Practice Guidelines as Topic
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents